Position in ENOV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,897,350
-$3,467,156 QoQ
Shares Held
83,400
-52.8% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
5 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in ENOV Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Trexquant Investment LP holds $264,507,021 across 41 Medical Devices names. ENOV ranks #25 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
547,076 | $43,809,846 | |
| 2 | SYK |
Stryker Corp
|
75,199 | $24,709,639 | |
| 3 | BSX |
Boston Scientific Corp
|
385,491 | $24,189,560 | |
| 4 | PODD |
Insulet Corp
|
102,230 | $21,451,943 | |
| 5 | DXCM |
Dexcom Inc
|
304,067 | $19,095,407 | |
| 6 | IRTC |
iRhythm Holdings, Inc.
|
111,311 | $13,136,924 | |
| 7 | HAE |
Haemonetics Corp
|
218,010 | $12,287,043 | |
| 8 | TMDX |
TransMedics Group, Inc.
|
106,300 | $10,567,283 |
All Filings in ENOV
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,897,350 | 83,400 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $5,364,506 | 176,813 | Shares | Sole | 2025-11-14 | |
| 2023-09-30 | $598,960 | 11,359 | Shares | Sole | 2023-11-13 | |
| 2022-12-31 | $238,271 | 4,452 | Shares | Sole | 2023-02-13 | |
| 2022-06-30 | $1,207,580 | 21,956 | Shares | Sole | 2022-08-11 | |
| No filing history on record for this holder in this stock. | ||||||